All Business articles – Page 9
-
BusinessShell to sell US refinery stake to Mexican state-owned petroleum company
Pemex will take full control of Deer Park refinery, as Mexico’s president moves to gain energy independence
-
Business
Striving to bolster the antibiotic pipeline before it becomes the next crisis
It’s been almost 10 years since the world was warned of a post-antibiotic apocalypse. Katrina Megget takes a look at the initiatives trying to support antimicrobial R&D
-
Business
US supreme court ends Sandoz–Amgen biosimilar dispute
Sandoz’s copy of arthritis drug Enbrel won’t be available in the US until 2029, 30 years after it was first marketed
-
Feature
How should chemical mixtures be regulated?
Nina Notman explores the challenge of assessing and managing risk from the coincidental chemical mixtures to which humans and the environment are exposed
-
Business
What might UK Reach look like?
As the UK’s legal system finds its feet post-Brexit, stakeholders have mixed feelings about the changes it could bring
-
Feature
Cleaning up industry’s water worries
With clean water supplies increasingly scarce, Angeli Mehta looks at what industry is doing to reduce its demands
-
Business
Coca-Cola chemist convicted of trade secret theft
Xiaorong You stole files detailing BPA-free can coatings from seven major chemicals firms
-
Business
Fatal explosion at US paint and polymers plant
One dead and nine others injured as building partially collapsed after explosion and fire
-
Business
Government clears merger of SinoChem and ChemChina
China’s chemicals giants will unite under a state-run holding company
-
Business
Making supercritical fluid extraction affordable with Nova Extraction
London-based duo wants this powerful technique to be cheaper and more widely accessible
-
Feature
The growing problem of pesticide resistance
Weeds and other plant pests can no longer be controlled by chemicals as easily as they could. Bárbara Pinho talks to the scientists finding solutions
-
Business
Antibody–drug conjugates drive growth in oncology
Antibody–drug conjugates are coming of age and pharma is investing, reports Katrina Megget
-
Business
Why manufacturing Covid vaccines at scale is hard
Exploring the pinch points vaccine makers face as they ramp up production
-
Feature
Flow chemistry surges forward
The long-discussed technique could help make pharma manufacturing more distributed, finds Andy Extance, and create opportunities for chemists with the right skills
-
Business
University team’s silica coats stop vaccines spoiling at room temperature
Asel Sartbaeva hopes her pioneering ensilication technology will be adopted to store and transport pediatric vaccines to low-income countries
-
Business
Chromosol’s silicon photonics system tackles data transfer bottleneck
Technology for integrating lasers directly into photonic circuits could accelerate replacement of large and expensive optical systems
-
Business
Polar storm paralyses US Gulf Coast petrochemical sector
Days after ‘icepocalypse’ hit Texas, 75% of US ethylene capacity was still offline, as was 70% of its polypropylene and 40% of propylene production
-
Business
Coronavirus variants stymie success of monoclonal antibodies
Lab-made antibodies can treat and protect people from Covid-19 but are more likely to succeed when administered as a cocktail
-
Business
BASF tightens austerity belt and closes plant in north of England
Political fallout over £1 billion Covid loan that preceded hexamethylene diamine plant closure
-
Opinion
A rough guide to pharma partnership deals
Coronavirus vaccines are driving unusual collaborations with a range of benefits
